首页> 外国专利> USE OF GLP-1 RECEPTOR AGONISTS AND/OR DPP-IV INHIBITORS IN COMBINATION WITH PROTON PUMP INHIBITORS AND PPAR AGONISTS FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF DIABETES TYPE I, DIABETES TYPE II AND IMPAIRED PANCREATIC BETA-CELL FUNCTION

USE OF GLP-1 RECEPTOR AGONISTS AND/OR DPP-IV INHIBITORS IN COMBINATION WITH PROTON PUMP INHIBITORS AND PPAR AGONISTS FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF DIABETES TYPE I, DIABETES TYPE II AND IMPAIRED PANCREATIC BETA-CELL FUNCTION

机译：将GLP-1受体激动剂和/或DPP-IV抑制剂与质子泵抑制剂和PPAR激动剂组合使用，以制备用于治疗I型，II型糖尿病和受损的胰蛋白酶功能的药物

页面导航

摘要
著录项
相似文献

摘要

Methods for treating diabetes by increasing the insulin secretion by administration of a GLP-1 receptor agonist and/or a DPP-IV inhibitor in combination with a proton pump inhibitor and optionally a PPAR agonist are provided.

机译：提供了通过与质子泵抑制剂和任选的PPAR激动剂组合施用GLP-1受体激动剂和/或DPP-IV抑制剂来增加胰岛素分泌来治疗糖尿病的方法。

著录项

公开/公告号EP1906991A2

专利类型
公开/公告日2008-04-09

原文格式PDF
申请/专利权人 NOVO NORDISK A/S;
展开▼

申请/专利号EP20050771972
发明设计人 PETERSEN JACOB STEN;HANSEN LARS;GALSGAARD ELISABETH D.;
展开▼

申请日2005-06-23
分类号A61K38/26;A61K31/4439;A61K31/192;A61P3/10;
国家 EP
入库时间 2022-08-21 19:56:19

相似文献

专利
外文文献
中文文献